Aesculap, Inc. to Participate at AANS 2013 Annual Meeting; featuring the Miethke proSA™ Shunt Valve – Booth 1730

At Ernest N. Morial Convention Center, Hall I, New Orleans, Louisiana

Center Valley, PA (April 26, 2013) – Aesculap, Inc., a leader in neurosurgery and surgical technology instruments is pleased to announce its participation at the AANS 2013 Annual Meeting from April 29 – May 1, 2013.  The meeting will take place at the Ernest N. Morial Convention Center in New Orleans.  

AANS will mark the U.S. launch of Aesculap’s global awareness campaign, “We understand the gravity of the situation.” The goal of the campaign is to highlight how Aesculap, Inc. strives to understand both the significant challenges faced by the surgeon, and the serious needs of the Hydrocephalus patient. Aesculap-Miethke gravitational shunt systems are based on the understanding that every patient is unique and deserves the best valve available to help them live a normal, healthy life. 

The latest example in innovative shunt technology is the Miethke proSA™ valve; the adjustable, gravitational shunt valve which offers surgeons treating Hydrocephalus the most flexible shunt system available, allowing the surgeon to provide the best treatment options to their patients.

  • Gravitational - Provides drainage protection in the upright position
  • Adjustable - Allows for independent control of lying and upright pressures
  • Flexible - Wide pressure range of 0-40 cm H2O offers the most treatment options
  • Safe - Integrated MR brake helps prevent setting changes in 1.5 and 3.0T MRIs

Christoph Miethke, President and Head of Research & Development at Christoph Miethke GMBH & Co. KG, will be attending AANS and available to answer questions about proSA.  Surgeons may visit the Aesculap booth to meet Miethke and learn more about the entire shunt valve portfolio.

In addition to proSA being on display, the Aesculap, Inc. Booth 1730 will also feature its latest developments in surgical technology for neurosurgeons:

 MINOP® InVent: A solution for the bi-manual resection of solid tumors and cysts, increased capacity to perform hemostasis and coagulation, and extended working range thru angled instrumentation.

 Hi-Line XXS: A high speed power system with a unique bayonet-shaped handpiece provides best in class visibility and improved maneuverability.  Hi-Line XXS is not cleared by the FDA for use in neurosurgery. 

 KAIRison™ : A Pneumatic Kerrison Bone Punch provides surgeons with excellent control and feedback with reduced physical effort; resulting in a declined risk of reduced motor skills through fatigue. 

 About Aesculap, Inc.

Aesculap, Inc., a B. Braun company, founded in 1867 in Tuttlingen, Germany, is the world’s largest and one of the most respected manufacturers of surgical instruments and sterilization container systems. Aesculap is a leading privately-owned manufacturing company, passionately committed to providing high-quality, innovative products and services to all surgical disciplines, with particular focus in the fields of General, Neuro, Spine and Orthopaedics. For more information, contact Aesculap Customer Service at 1-800-282-9000 or visit 

About B. Braun

B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its “Sharing Expertise®” philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

 The B.Braun group of companies includes B.Braun, Aesculap® and CAPS®. B.Braun’s U.S. headquarters is located in Bethlehem, Pennsylvania, with its global headquarters based in Melsungen, Germany. It employs more than 44,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit


Amy Burkey

Project Manager, Corporate Communications  

Aesculap, Inc.